GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (OTCPK:MLLCF) » Definitions » Inventories, Work In Process

MLLCF (Molecular Partners AG) Inventories, Work In Process : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Molecular Partners AG Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Molecular Partners AG's work in process for the quarter that ended in Sep. 2024 was $0.00 Mil.

Molecular Partners AG Inventories, Work In Process Historical Data

The historical data trend for Molecular Partners AG's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Inventories, Work In Process Chart

Molecular Partners AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Molecular Partners AG Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Molecular Partners AG Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Molecular Partners AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (OTCPK:MLLCF) » Definitions » Inventories, Work In Process
Comparable Companies
XSWX:NWRN XSWX:SANN XSWX:RLF XSWX:EVE XSWX:SPEX XSWX:OBSN XSWX:ADXN XSWX:KNRS XSWX:XLS XSWX:IDIA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
MOLN:USA MOLNz:UK 0QXX:UK MOLN:Switzerland
Address
Wagistrasse 14, Schlieren, Zurich, CHE, 8952
Website
https://www.molecularpartners.com
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.